CD8A and neoplasm: Re‐challenging the C3H mice with parental tumor cells also showed no tumor growth, but revealed an increased population of CD3+/CD8+ cells and elevated Th1 cytokine levels, suggesting systemic immunity resulting from IL‐24 treatment (Miyahara et al. 2006).